Metabolic effects of captopril in hypertensive patients

G. Perani, E. Gallanti, D. Corbellini, E. Maggi, C. Manzinali, E. Marchesi

Research output: Contribution to journalArticle

Abstract

The effects of captopril treatment (50 mg once daily or BID) on plasma lipoproteins and glucose and insulin responses to oral glucose loading were assessed in 15 patients with mild hypertension. No changes in lipid or lipoprotein levels were observed after eight and 16 weeks of captopril treatment. At the end of the study, postload glucose levels were significantly lower at 60, 90, and 180 minutes. The area under the curve was also significantly smaller. The early insulin response to oral stimulus was higher (P <0.05 at 60 minutes) on captopril treatment, whereas the late insulin response and the area under the curve were unchanged. The results are consistent with a captopril-induced enhancement of insulin-mediated glucose disposal. Antihypertensive treatment with captopril appears to exert no effects or even favorable effects on some of the metabolic derangements often associated with essential hypertension and therefore to produce an improvement of the whole cardiovascular risk profile in hypertensive patients.

Original languageEnglish
Pages (from-to)111-117
Number of pages7
JournalCurrent Therapeutic Research
Volume50
Issue number1
Publication statusPublished - 1991

Fingerprint

Captopril
Insulin
Glucose
Lipoproteins
Area Under Curve
Therapeutics
Antihypertensive Agents
Hypertension
Lipids

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Metabolic effects of captopril in hypertensive patients. / Perani, G.; Gallanti, E.; Corbellini, D.; Maggi, E.; Manzinali, C.; Marchesi, E.

In: Current Therapeutic Research, Vol. 50, No. 1, 1991, p. 111-117.

Research output: Contribution to journalArticle

Perani, G, Gallanti, E, Corbellini, D, Maggi, E, Manzinali, C & Marchesi, E 1991, 'Metabolic effects of captopril in hypertensive patients', Current Therapeutic Research, vol. 50, no. 1, pp. 111-117.
Perani, G. ; Gallanti, E. ; Corbellini, D. ; Maggi, E. ; Manzinali, C. ; Marchesi, E. / Metabolic effects of captopril in hypertensive patients. In: Current Therapeutic Research. 1991 ; Vol. 50, No. 1. pp. 111-117.
@article{7e3f96d4a2824ea0bde34bde8778568c,
title = "Metabolic effects of captopril in hypertensive patients",
abstract = "The effects of captopril treatment (50 mg once daily or BID) on plasma lipoproteins and glucose and insulin responses to oral glucose loading were assessed in 15 patients with mild hypertension. No changes in lipid or lipoprotein levels were observed after eight and 16 weeks of captopril treatment. At the end of the study, postload glucose levels were significantly lower at 60, 90, and 180 minutes. The area under the curve was also significantly smaller. The early insulin response to oral stimulus was higher (P <0.05 at 60 minutes) on captopril treatment, whereas the late insulin response and the area under the curve were unchanged. The results are consistent with a captopril-induced enhancement of insulin-mediated glucose disposal. Antihypertensive treatment with captopril appears to exert no effects or even favorable effects on some of the metabolic derangements often associated with essential hypertension and therefore to produce an improvement of the whole cardiovascular risk profile in hypertensive patients.",
author = "G. Perani and E. Gallanti and D. Corbellini and E. Maggi and C. Manzinali and E. Marchesi",
year = "1991",
language = "English",
volume = "50",
pages = "111--117",
journal = "Current Therapeutic Research - Clinical and Experimental",
issn = "0011-393X",
publisher = "Excerpta Medica",
number = "1",

}

TY - JOUR

T1 - Metabolic effects of captopril in hypertensive patients

AU - Perani, G.

AU - Gallanti, E.

AU - Corbellini, D.

AU - Maggi, E.

AU - Manzinali, C.

AU - Marchesi, E.

PY - 1991

Y1 - 1991

N2 - The effects of captopril treatment (50 mg once daily or BID) on plasma lipoproteins and glucose and insulin responses to oral glucose loading were assessed in 15 patients with mild hypertension. No changes in lipid or lipoprotein levels were observed after eight and 16 weeks of captopril treatment. At the end of the study, postload glucose levels were significantly lower at 60, 90, and 180 minutes. The area under the curve was also significantly smaller. The early insulin response to oral stimulus was higher (P <0.05 at 60 minutes) on captopril treatment, whereas the late insulin response and the area under the curve were unchanged. The results are consistent with a captopril-induced enhancement of insulin-mediated glucose disposal. Antihypertensive treatment with captopril appears to exert no effects or even favorable effects on some of the metabolic derangements often associated with essential hypertension and therefore to produce an improvement of the whole cardiovascular risk profile in hypertensive patients.

AB - The effects of captopril treatment (50 mg once daily or BID) on plasma lipoproteins and glucose and insulin responses to oral glucose loading were assessed in 15 patients with mild hypertension. No changes in lipid or lipoprotein levels were observed after eight and 16 weeks of captopril treatment. At the end of the study, postload glucose levels were significantly lower at 60, 90, and 180 minutes. The area under the curve was also significantly smaller. The early insulin response to oral stimulus was higher (P <0.05 at 60 minutes) on captopril treatment, whereas the late insulin response and the area under the curve were unchanged. The results are consistent with a captopril-induced enhancement of insulin-mediated glucose disposal. Antihypertensive treatment with captopril appears to exert no effects or even favorable effects on some of the metabolic derangements often associated with essential hypertension and therefore to produce an improvement of the whole cardiovascular risk profile in hypertensive patients.

UR - http://www.scopus.com/inward/record.url?scp=0025820711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025820711&partnerID=8YFLogxK

M3 - Article

VL - 50

SP - 111

EP - 117

JO - Current Therapeutic Research - Clinical and Experimental

JF - Current Therapeutic Research - Clinical and Experimental

SN - 0011-393X

IS - 1

ER -